首页> 美国卫生研究院文献>Biomedicines >Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration
【2h】

Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration

机译:用序贯离心超滤从人胶质母细胞瘤干细胞沉淀中分离的两种细胞外囊泡亚型的蛋白质组学特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Extracellular vesicles (EVs) released from tumor cells are actively investigated, since molecules therein contained and likely transferred to neighboring cells, supplying them with oncogenic information/functions, may represent cancer biomarkers and/or druggable targets. Here, we characterized by a proteomic point of view two EV subtypes isolated by sequential centrifugal ultrafiltration technique from culture medium of glioblastoma (GBM)-derived stem-like cells (GSCs) obtained from surgical specimens of human GBM, the most aggressive and lethal primary brain tumor. Electron microscopy and western blot analysis distinguished them into microvesicles (MVs) and exosomes (Exos). Two-dimensional electrophoresis followed by MALDI TOF analysis allowed us to identify, besides a common pool, sets of proteins specific for each EV subtypes with peculiar differences in their molecular/biological functions. Such a diversity was confirmed by identification of some top proteins selected in MVs and Exos. They were mainly chaperone or metabolic enzymes in MVs, whereas, in Exos, molecules are involved in cell–matrix adhesion, cell migration/aggressiveness, and chemotherapy resistance. These proteins, identified by EVs from primary GSCs and not GBM cell lines, could be regarded as new possible prognostic markers/druggable targets of the human tumor, although data need to be confirmed in EVs isolated from a greater GSC number.
机译:从肿瘤细胞中释放的细胞外囊泡(EVS)被主动研究,因为其中包含和可能转移到相邻细胞中,以致癌信息/功能提供给邻近的细胞,可以代表癌症生物标志物和/或可药物靶标。在此,我们的特征在于由胶质母细胞瘤(GBM)的培养基(GBM)的培养基(GSC)的培养基分离的两种EV亚型分离的蛋白质组学的观点,其来自人GBM的手术标本,最具侵略性和致死的原发性脑肿瘤。电子显微镜和Western印迹分析将它们区分成微泡(MVS)和外泌体(外壳)。二维电泳,然后是MALDI TOF分析,允许我们除了共同池之外,除了共同池之外,对每个EV亚型的蛋白质组特异于其分子/生物学功能的特殊差异。通过鉴定在MV和外部中选择的一些顶部蛋白质来证实这种多样性。它们主要是MV中的伴侣或代谢酶,而在外壳中,分子参与细胞基质粘附,细胞迁移/侵蚀性和化疗抗性。这些蛋白质由来自原发性GSCs和不是GBM细胞系的EVS鉴定的蛋白质可以被认为是人肿瘤的新可能的预后标记/可药物靶标,尽管在从更大的GSC数中分离的EVS中需要确认数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号